Medication info
Bonell Plus Tablet

Bonell Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201604713 · Approved 2016.07.29 · Insurance code 649807140

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly. Older adults: No dosage adjustment is necessary because the bioavailability and pharmacokinetics of this drug in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the drug reach the stomach readily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this drug. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily dose of vitamin D is 400 IU to 800 IU. Taking this drug once weekly provides one week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.
Child dose
Pediatric patients: Safety and efficacy have not been established in children and adolescents who are still growing.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used for the treatment and prevention of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly. Older adults: No dosage adjustment is necessary because the bioavailability and pharmacokinetics of this drug in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the drug reach the stomach readily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this drug. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily dose of vitamin D is 400 IU to 800 IU. Taking this drug once weekly provides one week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.

Child dose

Pediatric patients: Safety and efficacy have not been established in children and adolescents who are still growing.

Precautions

This medication may irritate the gastrointestinal mucosa, leading to adverse esophageal reactions such as esophagitis, esophageal ulcers, and esophageal erosion. If you experience problems with the esophagus, difficulty swallowing, pain behind the sternum, or heartburn, stop taking the medication immediately and consult a doctor. Always take this medication with plenty of water, and do not lie down for at least 30 minutes after taking it. Patients with delayed esophageal emptying or severe kidney impairment should not take this medication. Patients with hypersensitivity to this drug or lactose intolerance should also avoid taking it. It is advisable not to take medications or foods containing calcium, magnesium, iron, and aluminum simultaneously. Caution is necessary if undergoing dental surgery or oral infections due to the risk of jaw osteonecrosis, and maintaining oral hygiene is important. Pregnant or nursing women should consult a doctor, as taking this medication may affect the fetus or newborn. The safety for children has not been established, and it is advisable for children not to take this medication. Elderly patients can use it without special precautions, but they should consult a doctor if they have existing health conditions. Overdose may result in hypocalcemia, requiring immediate medical attention. This medication should be stored in a tightly sealed container, protected from direct sunlight and out of reach of children.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • abnormal function test results
Show 124 more
  • decreased serum calcium
  • decreased serum phosphorus
  • infection
  • back pain
  • pain
  • abdominal pain
  • throat pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension increase
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injuries due to accidents
  • influenza syndrome
  • headache
  • overdose
  • allergic reaction
  • tumor
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falls
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • rash
  • itching
  • low back pain
  • arthralgia
  • osteoarthritis
  • limb pain
  • muscle stiffness
  • myalgia
  • cervical pain
  • weakness
  • chest pain
  • fever
  • headache
  • dizziness
  • depression
  • hypercholesterolemia
  • hypercalcemia
  • hypocalcemia
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • jawbone necrosis
  • hepatic dysfunction
  • jaundice
  • external ear bone necrosis
  • anorexia
  • chest discomfort
  • palpitations
  • increased sweating
  • flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • elevated serum alkaline phosphatase
  • facial edema
  • hair loss
  • abnormal olfaction
  • cleft palate
  • vomiting
  • polyuria
  • weakness
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees at room temperature.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.